PH15619A - 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate - Google Patents

1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate

Info

Publication number
PH15619A
PH15619A PH21415A PH21415A PH15619A PH 15619 A PH15619 A PH 15619A PH 21415 A PH21415 A PH 21415A PH 21415 A PH21415 A PH 21415A PH 15619 A PH15619 A PH 15619A
Authority
PH
Philippines
Prior art keywords
tetrahydrofuroyl
quinazolinyl
dimethoxy
amino
piperazine hydrochloride
Prior art date
Application number
PH21415A
Other languages
English (en)
Inventor
Robert Roteman
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PH15619A publication Critical patent/PH15619A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
PH21415A 1977-08-04 1978-07-24 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate PH15619A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82167577A 1977-08-04 1977-08-04

Publications (1)

Publication Number Publication Date
PH15619A true PH15619A (en) 1983-02-28

Family

ID=25234014

Family Applications (1)

Application Number Title Priority Date Filing Date
PH21415A PH15619A (en) 1977-08-04 1978-07-24 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate

Country Status (4)

Country Link
JP (1) JPS63211229A (enrdf_load_stackoverflow)
MX (1) MX5483E (enrdf_load_stackoverflow)
PH (1) PH15619A (enrdf_load_stackoverflow)
SE (2) SE437157B (enrdf_load_stackoverflow)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride

Also Published As

Publication number Publication date
MX5483E (es) 1983-08-23
SE8400042D0 (sv) 1984-01-04
SE8400042L (sv) 1984-01-04
JPH0259127B2 (enrdf_load_stackoverflow) 1990-12-11
SE455373B (sv) 1988-07-11
SE7808316L (sv) 1979-02-05
JPS63211229A (ja) 1988-09-02
SE437157B (sv) 1985-02-11

Similar Documents

Publication Publication Date Title
AU517636B2 (en) 1 (4-amino-6, 7-dimethoxy-2-quinazolinyl) 4 (2 tetrahydrofuroyl) piperazine hydrochloride dihydrate
HK42781A (en) 4-amino-6,7-dimethoxy-2-(4-(heterocyclocarbonyl)piperozin-1-yl)quinazolines
NO832688L (no) 2-substituerte 4-amino-6,7-dimetoksykinoliner.
FI842544L (fi) Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.
IT7819724A0 (it) Carburo cementato.
DK210483D0 (da) Pyrogallolderivater, deres anvendelse og fremgangsmade til fremstilling deraf
PH14659A (en) 1-(3-or 4-substituted piperidino)phthalazones
IL51481A (en) Crystalline -form of-(4-(2-furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxy quinazoline hydrochloride and its preparation
AT350133B (de) Taschen-hoerhilfsgeraet
NZ187066A (en) 4-(3-substitutedamino-2-hydroxypropoxy)-benzimidazolidin-2-(ones or thiones)
FI854074A7 (fi) Peptidi-substituoituja heterosyklisiä immunostimulantteja.
NL7808319A (nl) 2-pyridyl- en 2-pyrimidylderivaten.
PH15619A (en) 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
FI790320A7 (fi) Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
CY1122A (en) 4-amino-6,7-dimethoxy-2-(4-(hetero-cyclo-carbonyl)piperazin-1-yl)quinazolines
AR217143A1 (es) Procedimiento de preparacion de nuevas 1-(piperonil),(2-naftil-metil)-,(3,4-etilendioxibencil)-,(5-cumaranil-metil)-y(5-benzoil(b)furanil-metil)-4-(1,3,4-tiadiazol-2-il)-piperazinas
PH22196A (en) Novel 4-(cyclic imido-substituted)-6,7-dimethoxy quinazoline derivatives
YU175483A (en) Process for obtining crystlline 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)-piperazine hydrochloride
YU171577A (en) Process for obtaining 2-(4-(2-furoyl)piperazine-1-yl)4-amino-6,7-dimethoxy-quinazoline
YU41908B (en) Process for proucing the crystalline form of 1-(4-amino-6,7-dimethoxy-2-quinazoliyl)-4-(2-furoyl)-piperazine hydrochloride
BG42903A1 (en) Method for preparing crystal alpha form of 1- (4- amino- 6, 7- dimetoxy- 2- quanazolyl)- 4- (2- furoyl)- piperazine hydrochloride
FI855121A0 (fi) Kopplingsanordning foer kommunikationsanlaeggningar, saerskilt telefonanlaeggningar, med till foermedlingsstaellen via ledningsknippen anslutna underfoermedlingsstaellen.
FI763613A7 (fi) Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin med blodtryckssaenkande verkan
BG47571A1 (en) Method for preparing of crystal alpha- form of 1- (4- amino- 6, 7- dimetoxy- 2- quinazolinyl)- 4- (2- furoyl)- piperazine hydrochloride
ES226152Y (es) Nuevo bloque ceramico.

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 14